AID  Vol.12 No.2 , June 2022
COVID-19 in Bouake (Côte D’Ivoire): Comparative Study of the Epidemiological, Clinical, Therapeutic, Evolutionary and Prognostic Aspects in Younger and Elderly Patients
Abstract: Introduction: The clinical manifestations of many diseases vary with age, and older people often do not show typical symptoms of the disease. The present study aims to compare the epidemiological, clinical, therapeutic and evolutionary aspects of elderly patients with COVID-19 compared to young adult patients and to identify risk factors for mortality. Patients and Methods: This was a retrospective single-center analytical study conducted from January 27, 2021 to January 27, 2022 at the COVID-19 Care Center of the Infectious and Tropical Diseases Department of the Bouaké University Teaching Hospital. The study population consisted of all patients aged at least 18 years seen in consultation and/or hospitalized with a positive COVID-19 RT-PCR. The patients were divided into two groups: younger patients (<60 years old) and elderly patients (≥60 years old). Data analysis was done with SPSS software. The statistical tests used were the chi-square test, Fisher’s exact test depending on the validity conditions and univariate and multivariate logistic regression with a significance level of 0.05. Results: Of a total of 779 patients, 644 (82.7%) were young. The median age of all patients was 41 years (IQR 32 - 54, extreme 18 and 96). Of all the patients 38.5% had a comorbidity. Compared to younger patients, chronic heart disease (61.7% vs 21.5%; p < 0.0001) and diabetes (23.4% vs 10.9%; p = 0.006) predominated in elderly patients. Patients were symptomatic in 89.2% of cases. In the elderly patients, the predominant symptoms were cough (85.1% vs 66%; p < 0.0001), dyspnea (48.7% vs 17.9%; p < 0.0001), ageusia (48.8% vs 24%; p < 0.0001), diarrhea (8.3% vs 3.3%; p = 0.013), impaired consciousness (4.1% vs 1.2%; p = 0.041) and insomnia (2.5 vs 0.3; p = 0.011). Younger patients were hemodynamically more stable unlike elderly patients (p < 0.0001). The therapeutic modalities were different in the two groups (p < 0.0001). The duration of confinement or hospitalization did not differ statistically according to the two groups (p = 0.551). The evolution was favourable in 92.9%. A total of 55 patients died, including 23 (3.6%) younger patients and 32 (23.7%) elderly patients with a significant difference between the two groups (p < 0.0001). Mortality risk factors were age (p < 0.001), dyspnea (p = 0.001), impaired consciousness (p = 0.020) and fever (p = 0.009). Conclusion: Elderly people with COVID-19 have a different clinical presentation from younger, characterized by more atypical symptoms. Mortality risk factors are age, dyspnoea, impaired consciousness and fever. It is therefore necessary to act on its various factors to improve the prognosis of COVID-19 in this age group.
Cite this paper: Djakaridja, K. , Juliette, K. , Alamun, A. , Tatiana, Y. , Renaud, K. , Marie, K. , Romeo, A. , Famoussa, K. , Akanbi, S. , Junior, S. , Thomas, A. and Ouffoue, K. (2022) COVID-19 in Bouake (Côte D’Ivoire): Comparative Study of the Epidemiological, Clinical, Therapeutic, Evolutionary and Prognostic Aspects in Younger and Elderly Patients. Advances in Infectious Diseases, 12, 312-327. doi: 10.4236/aid.2022.122025.

[1]   Wu, F., Zhao, S., Yu, B., Chen, Y.M., Wang, W., Song, Z.G., et al. (2020) A New Coronavirus Associated with Human Respiratory Disease in China. Nature, 579, 265-269.

[2]   OMS (2020) L’organisation Mondiale de la Santé déclare que la flambée de COVID-19 constitue une pandémie.

[3]   Worldometer (2020) COVID-19 Coronavirus Pandemic.

[4]   Palmieri, L., Vanacore, N., Donfrancesco, C., Lo Noce, C., Canevelli, M., Punzo, O., et al. (2020) Clinical Characteristics of Hospitalized Individuals Dying with COVID-19 by Age Group in Italy. The Journals of Gerontology: Series A, 75, 1796-1800.

[5]   Palmieri, L., Palmer, K., Lo Noce, C., Meli, P., Giuliano, M., Floridia, M., et al. (2020) Differences in the Clinical Characteristics of COVID-19 Patients Who Died in Hospital during Different Phases of the Pandemic: National Data from Italy. Aging Clinical and Experimental Research, 33, 193-199.

[6]   Centers of Disease and Control and Prevention (2020) Coronavirus Disease 2019 (COVID-19).

[7]   Bavaro, D.F., Diella, L., Fabrizio, C., Sulpasso, R., Bottalico, I.F., Calamo, A., et al. (2021) Peculiar Clinical Presentation of COVID-19 and Predictors of Mortality in the Elderly. A Multicentre Retrospective Cohort Study. International Journal of Infectious Diseases, 105, 709-715.

[8]   Wu, Z. and McGoogan, J.M. (2020) Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases from the Chinese Center for Disease Control and Prevention. JAMA, 323, 1239-1242.

[9]   Institut National de la Statistique (INS) (2017) Enquête par grappes à indicateurs multiples, 2016, Rapport des Résultats clés. Abidjan, Côte d’Ivoire.

[10]   UNICEF. Réseau Ivoirien de Suivi et d’Evaluation (RISE). Analyse Qualitative: Maladie à Coronavirus (COVID19) en Côte d’Ivoire.

[11]   Gebhard, C., Regitz-Zagrosek, V., Neuhauser, H.K., Morgan, R. and Klein, S.L. (2020) Impact of Sex and Gender on COVID-19 Outcomes in Europe. Biology of Sex Differences, 11, Article No. 29.

[12]   Kim, R., Nachman, S., Fernandes, R., Meyers, K., Taylor, M., LeBlanc, D., et al. (2020) Comparison of COVID-19 Infections among Healthcare Workers and Non-Healthcare Workers. PLoS One, 15, e0241956.

[13]   Guan, W., Ni, Z., Hu, Y., Eastin, C., Eastin, T., et al. (2020) Clinical Characteristics of Coronavirus Disease 2019 in China. The New England Journal of Medicine, 382, 1708-1720.

[14]   Richardson, S., Hirsch, J.S., Narasimhan, M., Crawford, J.M., McGinn, T., Davidson, K.W., et al. (2020) Presenting Characteristics, Comorbidities, and Outcomes among 5700 Patients Hospitalized with COVID-19 in the New York City Area. JAMA, 323, 2052-2059.

[15]   Niu, S., Tian, S., Lou, J., Kang, X., Zhang, L., Lian, H., et al. (2020) Clinical Characteristics of Older Patients Infected with COVID-19: A Descriptive Study. Archives of Gerontology and Geriatrics, 89, Article ID: 104058.

[16]   Chen, T., Dai, Z., Mo, P., Li, X., Ma, Z., Song, S., et al. (2020) Clinical Characteristics and Outcomes of Older Patients with Coronavirus Disease 2019 (COVID-19) in Wuhan, China (2019): A Single-Centered, Retrospective Study. The Journals of Gerontology: Series A, 75, 1788-1795.

[17]   Atkins, J.L., Masoli, J.A.H., Delgado, J., Pilling, L.C., Kuo, C.L., Kuchel, G.A., et al. (2020) Preexisting Comorbidities Predicting Severe COVID-19 in Older Adults in the UK Biobank Community Cohort. medRxiv, 75, 2224-2230.

[18]   Jung, C.-Y., Park, H., Kim, D.W., Choi, Y.J., Kim, S.W. and Chang, T.I. (2020) Clinical Characteristics of Asymptomatic Patients with COVID-19: A Nationwide Cohort Study in South Korea. International Journal of Infectious Diseases, 99, 266-268.

[19]   Tan, X., Zhang, S., Xu, J., Zhou, M., Huang, Q., Duan, L., et al. (2021) Comparison of Clinical Characteristics among Younger and Elderly Deceased Patients with COVID-19: A Retrospective Study. GING, 13, 16-26.

[20]   Gómez-Belda, A.B., Fernández-Garcés, M., Mateo-Sanchis, E., Madrazo, M., Carmona, M., Piles-Roger, L., et al. (2020) COVID-19 in Older Adults: What Are the Differences with Younger Patients? Geriatrics & Gerontology International, 21, 60-65.

[21]   Liu, K., Chen, Y., Lin, R. and Han, K. (2020) Clinical Features of Covid-19 in Elderly Patients: A Comparison with Young and Middle-Aged Patients. Journal of Infection, 80, E14-E18.

[22]   Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., et al. (2020) Clinical Course and Outcomes of Critically Ill Patients with SARS-CoV-2 Pneumonia in Wuhan, China: A Single-Centered, Retrospective, Observational Study. The Lancet Respiratory Medicine, 8, 475-481.

[23]   Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., et al. (2020) Clinical Course and Risk Factors for Mortality of Adult Inpatients with COVID-19 in Wuhan, China: A Retrospective Cohort Study. The Lancet, 395, 1054-1062.

[24]   Wang, J., Zhu, X., Xu, Z., Yang, G., Mao, G., Jia, Y., et al. (2020) Clinical and CT Findings of COVID-19: Differences among Three Age Groups. BMC Infectious Diseases, 20, Article No. 434.

[25]   Rees, E.M., Nightingale, E.S., Jafari, Y., Waterlow, N.R., Clifford, S., et al. (2020) COVID-19 Length of Hospital Stay: A Systematic Review and Data Synthesis. BMC Medicine, 18, Article No. 270.

[26]   Liu, X., Zhou, H., Zhou, Y., Wu, X., Zhao, Y., Lu, Y., et al. (2020) Risk Factors Associated with Disease Severity and Length of Hospital Stay in COVID-19 Patients. Journal of Infection, 81, E95-E97.

[27]   Zheng, H., Tan, J., Zhang, X., Luo, A., Wang, L., Zhu, W., et al. (2020) Impact of Sex and Age on Respiratory Support and Length of Hospital Stay among 1792 Patients with COVID-19 in Wuhan, China. British Journal of Anaesthesia, 125, E378-E380.

[28]   Chiam, T., Subedi, K., Chen, D., Best, E., Bianco, F.B., Dobler, G., et al. (2021) Hospital Length of Stay among COVID-19-Positive Patients. Journal of Clinical and Translational Research, 7, 377-385.

[29]   Zhang, L., Fan, T., Yang, S., Feng, H., Hao, B., Lu, Z., et al. (2020) Comparison of Clinical Characteristics of COVID-19 between Elderly Patients and Young Patients: A Study Based on a 28-Day Follow-Up. Aging, 12, 19898-19910.

[30]   Aviv, A. (2020) Telomeres and COVID-19. The FASEB Journal, 34, 7247-7252.

[31]   Crimmins, E.M. (2020) Age-Related Vulnerability to Coronavirus Disease 2019 (COVID-19): Biological, Contextual, and Policy-Related Factors. Public Policy & Aging Report, 30, 142-146.